Skip to content

Forward Bio

Active Private limited companyfounded 2023active for 3 yearsFresiastraat 2, 9031 GhentKBO/BCE: BE 0799.329.290

Annual accounts 2025

micro format, filed on 05-01-2026, 26 days before the deadline
€125,134
previous year 16 months
€122,266
previous year 16 months
€87,005
previous year 16 months
€228,510
▲ 58.6%
80.6%
▲ 16.8 percentage points
5.24
▲ 2.43

Turnover is estimated at about €210,000, probably between €180,000 and €240,000. The micro format does not state turnover.

Balance sheet

balance sheet total €287,166 on 30-06-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

80.6%

Higher than 78% of the 41,316 companies filing micro accounts in head offices and management consultancy (NACE 70) in 2025.

5.24

Higher than 79% of the 39,879 companies filing micro accounts in head offices and management consultancy (NACE 70) in 2025.

30.3%

Higher than 72% of the 40,402 companies filing micro accounts in head offices and management consultancy (NACE 70) in 2025.

Forward Bio Middle half of the sector 80% of the sector Micro accounts in head offices and management consultancy (NACE 70)

Net result: top quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend2025202416 months
124,990212,757
89,728150,092
2,22310,621
57,490-
228,510144,119
80.6%63.8%
5.242.81
0.240.57
37.6%99.1%
30.3%63.2%
over 100over 100

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend2025202416 months
Balance sheet: assets
20/58 287,166229,001
21/28 4,7565,257
22/27 4,3564,857
24 4,3564,857
28 400400
29/58 282,410223,744
40/41 25,88324,565
40 25,88324,565
54/58 255,596198,105
490/1 9321,074
Balance sheet: equity and liabilities
10/49 287,166229,001
10/15 231,401146,062
10/11 3,0003,000
13 228,401143,062
133 228,401143,062
17/49 55,76582,939
42/48 53,90079,625
44 4,2812,003
440/4 4,2812,003
45 44,14373,647
450/3 44,14373,647
47/48 5,4753,974
492/3 1,8663,314
Income statement
9900 125,134212,757
630 2,7245,364
640/8 144-
9901 122,266207,392
75/76B 05
75 05
65/66B 606503
65 606503
9903 121,661206,894
67/77 34,65662,166
9904 87,005144,728
9905 87,005144,728
Appropriation of the result
9906 87,005144,728
691/2 85,339143,062
6921 85,339143,062
694/7 1,6661,666
694 1,6661,666
Document PDFPDF

The full notes are in the filed accounts (PDF).

Source: Annual accounts 2025 (PDF), filed on 05-01-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
30-06-2025 micro format 05-01-2026 2026-00000607 PDF
30-06-2024 micro format 23-01-2025 2025-00008710 PDF

Investments

fixed assets acquired
Item30-06-202530-06-2024
Tangible fixed assets€2,223€10,221
Financial fixed assets-€400
€2,724€5,364

Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)

Insights on Forward Bio

Debt's share of the balance-sheet total falls from 36.2% to 19.4%. Equity is higher and debt is lower.

Next steps